Skip to main content
logo
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
14.37
+0.05 (0.35%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $4.00K in the quarter ending June 30, 2026, a decrease of -50.00%. This brings the company's revenue in the last twelve months to $27.00K, down -55.00% year-over-year. In the year 2025, Lyell Immunopharma had annual revenue of $36.00K, down -40.98%.

Revenue (ttm)
$27.00K
Revenue Growth
-55.00%
P/S Ratio
13,042.18
Revenue / Employee
$168
Employees
161
Market Cap
352.14M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.00K-25.00K-40.98%
Dec 31, 202461.00K-69.00K-53.08%
Dec 31, 2023130.00K-84.55M-99.85%
Dec 31, 202284.68M74.03M695.15%
Dec 31, 202110.65M2.89M37.31%
Dec 31, 20207.76M7.10M1,080.52%
Dec 31, 2019657.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals215.72M
Agenus132.69M
Q32 Bio53.74M
Sutro Biopharma45.70M
Zentalis Pharmaceuticals26.87M
Abeona Therapeutics25.52M
Upstream Bio3.16M
Palisade Bio500.00K
Revenue Rankings

LYEL News

More News